PINNACLE ASSOCIATES LTD - QIAGEN NV ownership

QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 164 filers reported holding QIAGEN NV in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of QIAGEN NV
ValueSharesWeighting
Q4 2014$346,000
+3.3%
14,7300.0%0.01%0.0%
Q3 2014$335,000
-6.2%
14,730
+0.9%
0.01%0.0%
Q2 2014$357,000
+19.0%
14,600
+2.7%
0.01%
+16.7%
Q1 2014$300,000
-12.0%
14,215
-0.7%
0.01%
-14.3%
Q4 2013$341,000
-5.5%
14,315
-15.1%
0.01%0.0%
Q3 2013$361,000
-14.3%
16,865
-20.3%
0.01%
-22.2%
Q2 2013$421,00021,1650.01%
Other shareholders
QIAGEN NV shareholders Q4 2013
NameSharesValueWeighting ↓
Hardman Johnston Global Advisors LLC 6,178,402$170,833,00011.32%
Tikvah Management LLC 369,425$10,215,0005.35%
BLUE JAY CAPITAL MANAGEMENT, LLC 360,000$9,954,0003.36%
Opus Point Partners Management, LLC 160,000$4,424,0002.92%
Exane Asset Management 106,238$2,910,304,0001.76%
Douglas C. Lane & Associates, Inc. 1,918,338$53,042,0001.44%
Granahan Investment Management 1,051,000$29,060,0001.00%
CRAMER ROSENTHAL MCGLYNN LLC 2,285,569$63,196,0000.95%
Sivik Global Healthcare LLC 70,000$1,936,0000.92%
PURA VIDA INVESTMENTS, LLC 78,668$2,175,0000.92%
View complete list of QIAGEN NV shareholders